$15 to $17, Priced at $12: What a Below-Range IPO Teaches Private Sellers

Orion180 Insurance Group priced its initial public offering on Thursday at $12 a share, below the $15 to $17 range it had marketed to investors, and raised $240 million. The stock opened at $11.50 on Friday and finished its first session down 4.2 percent, leaving the Florida homeowners insurer valued at about $1.14 billion against the $1.7 billion its range had implied at the top. For a private business owner, the mechanics of an IPO can seem remote. The lesson is not: a marketed range is a question put to buyers, and this week the buyers answered.

What happened

Orion180 sold 20 million Class A shares through a syndicate led by RBC Capital Markets, UBS, and Raymond James, with a 30-day option for the underwriters to buy up to 3 million more. At the $16 midpoint of the range, those 20 million shares would have raised $320 million. At $12 they raised $240 million, a shortfall of $80 million, or 25 percent. Put the other way, raising the $320 million the company had planned for would have required selling about 26.7 million shares at the final price, a third more dilution than the roadshow assumed.

The company is not a distressed seller. Founded in 2018 and based in Melbourne, Florida, Orion180 is the second-largest writer of excess and surplus lines homeowners insurance in the country by direct written premiums. Excess and surplus, or E&S, is the part of the market that covers risks standard carriers will not write on standard terms, and in coastal states that increasingly means homeowners coverage. The company reported 69 percent premium growth in 2025, swung from a $3 million net loss to $13.5 million of net income in the first half of 2026, and placed a $1.15 billion reinsurance program backed by 41 reinsurers. It writes in 14 states, with Texas, California, and Florida the largest.

Those are the numbers a seller leads with. Investors read them, and priced the company 20 percent below the bottom of its range anyway.

Why a range is a hypothesis, not a price

An IPO price range is set by the company and its bankers a couple of weeks before pricing, based on comparable companies, recent transactions, and early conversations with large investors. The roadshow then builds a book of indications: who wants shares, how many, and at what price. The final price is wherever demand clears the shares on offer with enough left over to support trading afterward.

Three things moved against Orion180 between setting the range and pricing the deal.

The first was the macro backdrop. The Federal Reserve raised rates a quarter point on Wednesday, its first hike since 2023, and the 10-year Treasury yield ended the week just under 5 percent. New listings have no trading history to anchor value, so when rates and equity markets are moving, IPO investors demand a larger discount to compensate for the uncertainty. Reuters described the fall IPO season as a difficult start.

The second was the comparable. Orion180 set terms that implied a valuation multiple well above what CVC Capital Partners paid for rival Bamboo Insurance in a majority-stake transaction late last year, a deal that valued Bamboo at $1.75 billion. Bamboo launched its own IPO roadshow the same week, seeking up to $700 million at $18 to $20 a share and a fully diluted valuation of as much as $3.24 billion. Investors weighing Orion180 had a second insurer in front of them, a recent private-market price for that insurer, and the ability to wait a week. Competition among sellers for the same buyers is not the same as competition among buyers for the same asset.

The third was sector scrutiny. Renaissance Capital's Nicholas Einhorn noted that insurance IPO investors examine these companies closely and that some have had to prove themselves after listing. A homeowners insurer concentrated in catastrophe-exposed states, pricing in the middle of hurricane season, is a business investors can admire and still insist on buying at a discount.

The decision at the print

When a book comes in below the range, the seller has two choices, and both are expensive.

The first is to proceed at the market's price. Orion180 did. The cost is the $80 million it did not raise, or the dilution it would take to raise it later. The benefits are less visible but real: $240 million of permanent capital in a business where capital supports premium growth, a public currency for acquisitions, and the advantage of pricing ahead of Bamboo rather than behind it. Kenneth Gregg, the founder and chief executive, told Reuters the decision was right for the business and its team regardless of the macro environment.

The second choice is to pull the deal and wait. That preserves the range on paper, but not the valuation. The market has already seen the book, and a postponed IPO returns with stale financials and a buyer pool that remembers the first attempt. For a company that needs the capital, waiting also forgoes the growth the capital was meant to fund.

Neither choice is wrong in the abstract. The point is that the choice existed only because the range was set where the book did not follow. A range of $12 to $14 would have priced at the low end, raised the same $240 million, and produced a headline about an IPO that priced within range. The money would have been identical. The signal would not.

The private-market version of the same problem

Owners selling a private company face the same structure, with different vocabulary.

The confidential information memorandum, the marketing document a banker circulates to potential buyers, usually carries no stated price, but the process around it does. The banker's guidance on value, the quality of earnings report that presents adjusted EBITDA, and the seller's own conversations all set an implied range. Indications of interest come back as ranges, and the seller selects a shortlist from them. Then diligence happens, and the letter of intent arrives at a specific number, often below the indication that earned the buyer its spot. Sellers call this a re-trade. Buyers call it price discovery.

The same three forces apply. Financing costs moved in September, and a sponsor's model that assumed a lower rate now supports a lower price. A recent trade in your sector at a lower multiple is an anchor you do not control. And a business with customer concentration, key-person dependence, or exposure to a single geography will be diligenced harder and priced with a wider margin for error.

The lesson is not to set a low range; a range set too low leaves money with the buyer. The lesson is to set a range the book can support, which requires knowing the book before the range is published. In an IPO, that is the pre-marketing phase. In a private sale, it is the pre-launch work: identifying the likely buyers, understanding what each has paid recently and how each finances a deal, and testing the valuation narrative with a few trusted parties before it goes to everyone.

What to watch next

Bamboo's pricing next week is the immediate test. If it clears within its $18 to $20 range, the market will have said that Orion180's discount was company-specific: the carrier balance sheet, the coastal concentration, the reinsurance dependence. If Bamboo also prices below range, the discount belongs to the sector and the season, and every insurer planning a listing this year will recalibrate. Whether the underwriters exercise the 3 million share option will show what they think of aftermarket demand. And Orion180's first two quarters as a public company will determine whether $12 becomes a floor or a ceiling.